-
Mashup Score: 18Smartwatch-Guided “Pill-in-a-Pocket” Anticoagulation for Atrial Fibrillation: The REACT-AF Trial - 2 month(s) ago
The advent of numerous wearable devices, including atrial fibrillation (AF)-sensing smartwatches that are capable of detecting AF has opened the possibility that direct oral anticoagulation could be prescribed for only a few days after an episode of AF, rather than constantly.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 1
AbstractBackground and Aims. Reports of outcomes after atrial fibrillation (AF) diagnosis are conflicting. The aim of this study was to investigate mortality an
Source: academic.oup.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 15Trends in atrial fibrillation-related mortality in Europe, 2008–2019 - 2 month(s) ago
The atrial-fibrillation-related mortality trend has increased in Europe during the past decade.
Source: academic.oup.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation | Clinical Research Trial Listing - 2 month(s) ago
REACT-AF is a multicenter prospective, randomized, open-label, blinded endpoint (PROBE design), controlled trial comparing the current Standard Of Care (SOC) of continuous Direct Oral Anticoagulation (DOAC) use versus time-delimited (1 month) DOAC guided by an AF-sensing Smart Watch (AFSW) in participants with a history of paroxysmal or persistent Atrial Fibrillation (AF) and low-to-moderate stroke risk.
Source: www.centerwatch.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 5Atrial fibrillation: stroke prevention - 2 month(s) ago
Stroke prevention is central to the management of patients with atrial fibrillation (AF) which has moved towards a more holistic or integrative care a…
Source: www.sciencedirect.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 19Atrial fibrillation: epidemiology, screening and digital health - 2 month(s) ago
Atrial fibrillation (AF) is highly prevalent with a lifetime risk of about 1 in 3–5 individuals after the age of 45 years. Between 2010 and 2019, the global prevalence of AF has risen markedly from 33.5 million to 59 million individuals living with AF. Early detection of AF and implementation of appropriate treatment could reduce the frequency of complications associated with AF. International AF management guidelines recommend opportunistic and systematic screening for AF, but additional data are needed.
Source: www.thelancet.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1Hemodialysis before kidney transplant increases risk for AF vs. peritoneal dialysis - 2 month(s) ago
Patients who receive hemodialysis vs. peritoneal dialysis before kidney transplantation may be at higher risk for developing atrial fibrillation after the transplant, a study found.“The prevalence of [atrial fibrillation (AF)] is higher in the kidney failure population than in the general population and its incidence increases with lower [eGFR] and increasing proteinuria,” Leonardo
Source: www.healio.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 15What is cardiac ablation and how does it treat atrial fibrillation? - 3 month(s) ago
People with AFib have five times the risk of stroke. Learn how the three types of ablation work to restore a normal heart rhythm.
Source: news.bostonscientific.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 5Atrial fibrillation: stroke prevention - 3 month(s) ago
Stroke prevention is central to the management of patients with atrial fibrillation (AF) which has moved towards a more holistic or integrative care a…
Source: www.sciencedirect.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 40NOAC vs. Warfarin for AF Across BMI and Body Weight - American College of Cardiology - 3 month(s) ago
Debabrata Mukherjee, MD, FACC
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
Smartwatch-Guided “Pill-in-a-Pocket” Anticoagulation for #AFib: The REACT-AF Trial https://t.co/JGEuRjrAyL @DrBradleyKnight https://t.co/dlkAVv0ogj